In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2)

39Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

We tested the in-vitro activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, trimethoprim-sulphamethoxazole, tetracycline, norfloxacin, ciprofloxacin, vancomycin, teicoplanin, clindamycin and five psychiatric drugs (chlorpromazine, sertraline, fluoxetine, paroxetine and risperidone) against 32 strains of Corynebacterium urealyticum. Resistance rates exceeded 90% for all antibiotics except glycopeptides, quinolones and tetracycline. Sertraline was the most active psychiatric drug. We tested the influence of sertraline on the activity of amoxycillin, amoxycillin/clavulanic acid, cefotaxime, gentamicin, trimethoprim-sulphamethoxazole, tetracycline and ciprofloxacin. We did not observe antagonism in any case. Sertraline enhanced the activity of ciprofloxacin and tetracycline against all strains (MIC decrease: 4-64-fold for ciprofloxacin, 2-32-fold for tetracycline).

Cite

CITATION STYLE

APA

Muñoz-Bellido, J. L., Muñoz-Criado, S., & García-Rodríguez, J. A. (1996). In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). Journal of Antimicrobial Chemotherapy, 37(5), 1005–1009. https://doi.org/10.1093/jac/37.5.1005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free